The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Fixed-dose combination drugs: Innovative formulation and development strategies for bringing best-in-class products to market
Whitepaper
Fixed dose combination drugs (FDCs) have become an important alternative to monotherapy in the treatment of many diseases and conditions, including hypertension, diabetes, cancer, tuberculosis, asthma and COPD, and they hold promise for many more. Our tools can accurately identify effective combinations for many drugs on the market and help avoid those that may be problematic. By identifying potentially effective combinations or indications, our digital analytics can expedite time to market for novel therapies, benefitting patients and patent holders.